Renal cortical oxygen tension is decreased following exposure to long-term but not short-term intermittent hypoxia in the rat by O'Neill, Julie et al.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title Renal cortical oxygen tension is decreased following exposure to long-
term but not short-term intermittent hypoxia in the rat
Author(s) O'Neill, Julie; Jasionek, Greg; Drummond, Sarah E.; Brett, Orla;
Lucking, Eric F.; Abdulla, Mohammed A.; O'Halloran, Ken D.
Publication date 2019-01-16
Original citation O'Neill, J., Jasionek, G., Drummond, S. E., Brett, O., Lucking, E. F.,
Abdulla, M. A. and O'Halloran, K. D. (2019) 'Renal cortical oxygen
tension is decreased following exposure to long-term but not short-term
intermittent hypoxia in the rat', American Journal of Physiology -  Renal
Physiology. doi:10.1152/ajprenal.00254.2018




Access to the full text of the published version may require a
subscription.
Rights © 2019, American Journal of Physiology-Renal Physiology. All
rights reserved.
Embargo information Access to this article is restricted until 12 months after publication by
request of the publisher.





Renal Cortical Oxygen Tension is Decreased Following Exposure to Long-term but not 1 
Short-term Intermittent Hypoxia in the Rat 2 
 3 
Julie O’Neill, Greg Jasionek, Sarah E. Drummond, Orla Brett, Eric F. Lucking, Mohammed A. 4 
Abdulla, and Ken D. O’Halloran. 5 
Department of Physiology, School of Medicine, College of Medicine and Health, University 6 
College Cork, Cork, Ireland. 7 
Running Title: Inefficient O2 utilization in renal cortex following chronic intermittent hypoxia 8 
Corresponding author: 9 
Julie O´Neill, PhD 10 
Department of Physiology 11 
School of Medicine 12 
College of Medicine and Health 13 
University College Cork 14 
Cork, Ireland 15 
 16 





















Downloaded from www.physiology.org/journal/ajprenal by ${individualUser.givenNames} ${individualUser.surname} (143.239.102.069) on January 23, 2019.
Abstract: 38 
Chronic kidney disease (CKD) occurs in more than 50% of patients with obstructive sleep apnea 39 
(OSA). However, the impact of intermittent hypoxia (IH) on renal function and oxygen 40 
homeostasis is unclear. Male Sprague Dawley rats were exposed to IH (270 secs at 21% O2; 90 41 
secs hypoxia, 6.5% O2 at nadir) for 4 h (AIH) or to chronic IH (CIH) for 8h/day for 2 weeks. 42 
Animals were anesthetized and surgically prepared for the measurement of mean arterial 43 
pressure (MAP), and left renal excretory function, renal blood flow (RBF), and renal oxygen 44 
tension (PO2). AIH had no effect on MAP (123±14 versus (v) 129±14mmHg, mean±SEM, sham 45 
v IH). The CIH group were hypertensive (122±9 v 144±15mmHg, P<0.05). Glomerular filtration 46 
rate (GFR) (0.92±0.27 v 1.33±0.33ml/min), RBF (3.8±1.5 v 7.2±2.4ml/min) and transported 47 
sodium (TNa) (132±39 v 201±47μmol/min) were increased in the AIH group (all P<0.05). In the 48 
CIH group, GFR (1.25±0.28 v 0.86±0.28ml/min, P<0.05) and TNa (160±39 v 120±40μmol/min, 49 
P<0.05) were decreased, while RBF (4.13±1.5 v 3.08±1.5ml/min) was not significantly different. 50 
Oxygen consumption (QO2) was increased in the AIH group (6.76±2.60 v 13.60±7.77μmol/min, 51 
P<0.05), but was not significantly altered in the CIH group (3.97±2.63 v 6.82±3.29μmol/min). 52 
Cortical PO2 was not significantly different in the AIH group (46±4 v 46±3mmHg), but was 53 
decreased in the CIH group (44±5mmHg v 38±2mmHg, P<0.05). AIH: Renal oxygen 54 
homeostasis was preserved through a maintained balance between O2 supply (RBF) and 55 
consumption (GFR). CIH: Mismatched TNa and QO2 reflects inefficient O2 utilization and 56 
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 63 
Introduction: 64 
Chronic Kidney Disease (CKD) is characterized by structural and functional alterations in 65 
glomeruli and renal tubules, which grossly impair filtration of blood plasma and the renal 66 
handling of important electrolytes such as sodium. Classical clinical manifestations of CKD are 67 
abnormal glomerular filtration and proteinuria (2). Indeed, it is well established that CKD is a 68 
co-morbidity of disease pathologies such as diabetes mellitus, hypertension, chronic 69 
glomerulonephritis and cystic kidney disease (14). A sustained decrease in renal tissue oxygen 70 
availability has been reported in a variety of CKD models (10, 14, 27, 34). Importantly, it has 71 
been demonstrated that sustained renal tissue hypoxia precedes albuminuria in a mouse model of 72 
type 1 diabetes (12). Furthermore, proteinuria and immune cell infiltration resulted from an 73 
increase in renal oxygen consumption and kidney tissue hypoxia in an animal model not 74 
confounded by hyperglycameia or oxidative stress (chronic di-nitrophenol administration)  (41).  75 
Together these data provide evidence that kidney tissue hypoxia per se plays a potentially 76 
important role in the pathogenesis of CKD. 77 
 78 
It is now apparent that obstructive sleep apnea (OSA), which is characterized by repetitive cycles 79 
of upper airway obstruction and resultant intermittent hypoxemia throughout the sleep cycle, 80 
occurs in more than 50% of patients with CKD (2, 13).  Moreover, clinical data suggest that 81 
there is a correlation between OSA and glomerular hyperfiltration and proteinuria (2). Indeed a 82 
number of possible pathophysiological links between OSA and CKD have been proposed and it 83 
is plausible that exposure to CIH and thereby intermittent hypoxemia as well as sleep 84 
fragmentation, which manifest in OSA, may contribute to CKD progression via the activation of 85 
pro-oxidant (i.e. oxidative stress) (37,60), pro-inflammatory (NF-ΚB pathway) (43,59) and pro-86 
fibrotic pathways (sympathetic nervous system (SNS) and renin-aldosterone-angiotensin system 87 
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(RAAS) activation) (6,11,37). Indeed, the chronic repetitive cycles of blood 88 
deoxygenation/reoxygenation observed in experimental models of CIH have been shown to 89 
promote oxidative stress and inflammation both systemically and in the kidney (48,58)  90 
 91 
However, the impact of IH per se on renal function is unclear and data describing the effects of 92 
IH on renal hemodynamics and tubular function, both of which are defective in CKD appears to 93 
be lacking. Moreover, given that a sustained decrease in kidney tissue PO2 is now widely 94 
regarded as an important factor in the pathogenesis of secondary CKD (10, 14, 27)it would seem 95 
pertinent to determine both the immediate  and long-term impact of IH on renal function and 96 
renal oxygen homeostasis. Thus the aim of the present study was twofold: Firstly, we aimed to 97 
determine the impact of acute IH (AIH) and CIH on renal hemodynamics, excretory function and 98 
metabolism. Secondly, we aimed to determine whether CIH-induced alterations in renal 99 
hemodynamics, excretory function and oxygen homeostasis are consistent with the current 100 
understanding of the pathogenesis of CKD.  101 
 102 








Materials and Methods:  111 
Ethical Approval 112 
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Male Sprague Dawley rats (8-10 weeks old) were obtained from the Biological Services Unit in 113 
University College Cork and maintained there under a 12h light-12h dark regimen at 20±30C. 114 
Animals received free access to standard chow and water. All experimental procedures were 115 
performed under the European Community Directive 86/609/EC and were approved by the local 116 
Animal Experimentation Ethics Committee (AEEC number: 2013/005). NIH guidelines for the 117 
care of experimental animals were adhered to throughout each protocol.  118 
Animal Models of Intermittent Hypoxia (IH) 119 
 120 
IH Profile 121 
Animals were exposed to 10 cycles of IH per hour with each 6 min cycle consisting of 270 secs 122 
at 21% O2 (normoxia) and 90secs of hypoxia with a gradual decline in chamber oxygen to a 123 
nadir of 6.5% O2.  124 
 125 
Acute Intermittent Hypoxia (AIH) 126 
Acute exposure of animals (n=7) to the above-described IH profile was carried out over a period 127 
of 4 hours (08:00/09:00 to 12:00/13:00 hrs) in a commercial plethysmography chamber. A 128 
dynamic O2/N2 controller (GSM-3 Gas Mixer, CWE Inc., USA) was used to create the IH profile 129 
and to deliver alternating levels of gas to a mixing chamber, which subsequently delivered gases 130 
to the plethysmography chamber. Chamber O2 and CO2 levels were monitored throughout the 131 
exposure.  132 
 133 
Bedding was added to the chamber to enrich the environment and promote acclimation. Animals 134 
had ad libitum access to standard chow and water throughout the exposure. Once animals were 135 
placed in the chamber, a settling period of 30-40 minutes was sufficient to allow for the 136 
stabilization of respiration and environmental acclimation. The corresponding sham group (n=6) 137 
was exposed to air (21% O2) under identical experimental conditions.  138 
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 139 
Chronic Intermittent Hypoxia (CIH) 140 
Chronic exposure of animals (n=7) to IH was carried out over a period of 8 hours/day (08:00 141 
to16:00 hrs) for 2 weeks using a dynamic O2/CO2 controller (Oxycycler TM; Biospheric, NY, 142 
USA). Chamber oxygen levels were measured continuously and controlled. Gas flow rates were 143 
sufficient to prevent the accumulation of carbon dioxide in the chamber. Animals were placed in 144 
their cage environment into environmental chambers, with ad libitum access to standard chow 145 
and water. Sham animals (n=9) were housed in a similar environment with normoxia maintained 146 
over 14 days. IH profiles for acute and chronic studies were matched. The IH profile was 147 
designed so that the rate of de-oxygenation and re-oxygenation in all cycles were approximately 148 
equivalent in each experimental context. Experiments were conducted in AIH exposed animals 149 
and corresponding sham animals  immediately following the 4hr exposure to IH to evaluate the 150 
immediate and acute effects of repetitive de-oxygenation/re-oxygenation cycles. Experiments 151 
were conducted in CIH exposed animals one day following the last IH exposure (ie day 15) to 152 
evaluate the chronic and latent effects of repetitive de-oxygenation/re-oxygenation cycles.  153 
Surgical Protocol 154 
Following AIH or CIH exposure, animals were anesthetized via an intraperitoneal injection of 155 
sodium pentobarbitone (Euthatal), (60 mg/kg) and placed on a heated pad so that body 156 
temperature was maintained at 37°C. Adequacy of anesthesia was confirmed by absence of pedal 157 
withdrawal to noxious pinch. Supplemental doses of anesthetic were administered if required. A 158 
tracheostomy was performed (PP240 tubing) to facilitate respiration by spontaneous breathing. A 159 
cannula was inserted into the right carotid artery (PP50) to facilitate the measurement of mean 160 
arterial pressure (MAP) and into the right femoral vein to facilitate the infusion of Fluorescein 161 
isothyocyanate-Inulin (FITC-Inulin) (Sigma Aldrich, St Louis, Missouri, USA) (10mg/kg/hr). 162 
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The animals were studied with their dorsal aspect exposed and the left kidney was exposed by a 163 
left subcostal flank incision. The left kidney was then stabilized in a cup and surrounded and 164 
covered by cotton wool soaked in paraffin oil (Sigma Aldrich, St Louis, Missouri, USA). This 165 
was carried out to ensure that the kidney remained moist at body temperature. The left renal vein 166 
was dissected and prepared for the withdrawal of blood samples for the measurement of blood 167 
gases and oxygen consumption (QO2). 0.1 ml of venous blood was withdrawn very slowly from 168 
the renal vein using a 1 ml heparinized syringe and needle (27G) (BD Microlance). The entry 169 
site on the vein was sealed afterwards using an absorbable hemostatic gelatin sponge 170 
(Spongostan, Søberg, Denmark). The left renal artery was carefully dissected to facilitate the 171 
placement of a transit time ultrasound flow probe around the renal artery (renal blood flow 172 
(RBF) measurement) (Transconic. Systems, Ithaca, NY,USA). A cannula was inserted into the 173 
left ureter to facilitate the measurement of left renal function. Animals were allowed to stabilize 174 
for 45 minutes prior to the start of the experimental protocol. At the end of the experiment, 175 
animals were euthanized by an anesthetic overdose. 176 
Experimental Protocol 177 
The experimental protocol is summarized and described in Fig. 1. 178 
Measurement of hemodynamic parameters 179 
MAP was measured via the right carotid artery cannula, which was connected to a blood pressure 180 
transducer and a signal transduction amplifier. MAP was continuously monitored and recorded 181 
(AD Instruments, Hastings, UK). RBF was determined using a transonic flow probe, which was 182 
cupped around the renal artery and connected to a flow meter (Transonic Systems Inc, NY, 183 
USA). RBF was continuously monitored and recorded. Glomerular filtration rate (GFR) was 184 
determined by the clearance of FITC-Inulin. FITC fluorescence was measured in both urine and 185 
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plasma using a microplate reader (Wallac victor2 1420 multilabel counter, Perkin Elmer, USA). 186 
Blood gases and electrolytes were measured in blood withdrawn from the carotid artery and renal 187 
vein using the iSTAT system (Abbott Laboratories, Abbott Park, IL, USA). 188 
Measurement of excretory parameters 189 
Urine flow was determined gravimetrically at baseline. Urinary sodium concentrations were 190 
determined using flame spectrophotometry (model: M410, Sherwood Scientific, Ltd., UK). 191 
Urinary protein excretion (UPE) was measured using a BCA protein assay (Bio-Rad 192 
Laboratories, Hercules, California, USA). Urinary kidney injury molecule-1 (KIM-1) excretion 193 
was measured in sham (n=5) and CIH (n=5) groups using a KIM-1 ELISA kit (rat) purchased 194 
from GenWay Biotech, Inc. San Diego, California, USA. A multilabel plate reader was used at 195 
an absorbance of 450nm to quantify urinary protein concentrations and KIM-1 concentrations, 196 
after which both were normalized to urine flow rate.  197 
In vivo measurement of oxygen tension in the renal cortex and medulla 198 
At the end of each 40 min clearance period, PO2 sensing probes (Product no: PO2 E series ref 199 
BF/OT/E) (fluorescence quenching oximetry) (OxyLite 2000, Oxford Optronics Ltd, Abingdon, 200 
UK) were used to measure both cortical and medullary PO2. Probes were placed in 201 
micromanipulators. A small portion of the renal capsule was removed from the surface of the 202 
outer third of the kidney along the greater curvature. Once it was established that the tip of the 203 
probe was interfacing with the surface of the kidney (coincident with the partial pressure of 204 
oxygen falling from 120 mmHg to 100 mmHg), it was advanced 0.5-1.0 mm into the renal 205 
cortex. As soon as the recording became stable, a measurement was taken. The probe was then 206 
advanced a further 2.5 -3 mm in to the medulla (total depth 3.5-4 mm from kidney surface). 207 
Again once the recording became stable a measurement was taken. This was carried out several 208 
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times and the average cortical and medullary values were obtained. Importantly, after each set of 209 
cortical and medullary recordings the probe was completely removed from the kidney and 210 
reinserted in an area immediately adjacent (“undamaged area”) to the previous point of insertion.  211 
Tissue Homogenization 212 
Cortical and medullary tissue were weighed and homogenized in radio-immunoprecipitation 213 
assay RIPA lysis buffer (10% w/v) consisting of: 10x RIPA, deionized H2O, sodium fluoride 214 
(NaF) (200mM) phenylmethylsulfonylfluoride (PMSF) (100mM), protease cocktail inhibitor 215 
((5mM EDTA, 1 mM EGTA, 5µg/ml leupeptin, 5µg/ml aprotinin, 2µg/ml pepstatin, 120µg/ml 216 
Pefabloc, 2mM 1,10-phenanthroline and sodium orthovanadate (Naortho) (200mM) (All from 217 
Sigma Aldrich, Arklow, Wicklow, Ireland). Samples were homogenized on ice for 3 X 10 218 
second bursts with 30 seconds lapsing between each burst. The homogenates were left on ice for 219 
20 minutes with intermittent vortexing to allow cells to lyse. Samples were centrifuged at 220 
15,366g at 4°C for 15 min to pellet debris from homogenates.  221 
Nitric oxide (NO) and Oxidative Stress: 222 
Urinary, plasma and renal tissue nitrate/nitrite (NOx) levels were measured using a nitrate/nitrite 223 
colorimetric assay kit (Cayman Chemical, Michigan, USA) and all samples were assayed in 224 
duplicate. A multilabelled plate reader at an absorbance of 540nm quantified concentrations. 225 
Plasma and renal tissue thiobarbituric acid reactive substances (TBARS) were measured using a 226 
laboratory based thiobarbituric acid assay (Persson et al 2014) and the concentration of TBARS 227 
in the kidney and plasma was quantified by a multilabelled fluorescent plate reader (excitation: 228 
523nm, emission: 553nm). 229 
 230 
Markers of renal inflammation 231 
Downloaded from www.physiology.org/journal/ajprenal by ${individualUser.givenNames} ${individualUser.surname} (143.239.102.069) on January 23, 2019.
Renal cortical tissue homogenates were profiled for the following cytokine levels: Interferon 232 
(IFN)-γ, Interleukin-1β (IL-1β), IL-4, IL-5, IL-6, keratinocyte chemoattractant/growth related 233 
oncogene (KC/GRO), IL-10, IL-13 and tumor necrosis factor (TNF)-α. This was carried out by 234 
sandwich immunoassay methods using commercially available detection kits (V-plex Pro-235 
inflammatory Panel 2 (rat) kit; Meso Scale Discovery, Rockville, Maryland, USA) as per 236 
manufacturer’s instruction. 200μg of protein from each tissue sample was loaded in duplicate 237 
into wells. Plates were analyzed using a QuickPlex SQ 120 plate reader (Meso Scale Discovery, 238 
Rockville, Maryland, USA.) IL-4, IL-5 and IL-13 levels could not be established in the renal 239 
cortex in the present study because their levels were below the limits of detection. INF-γ was 240 not detected in 1 AIH and 1 sham sample.  241 
 242 
Gene Expression 243 
RNA extraction and gene reverse transcription  244 
RNA extraction and reverse transcription was carried out as previously described (29). Briefly, 245 
RNA was extracted, using Tripure Isolation Reagent (Roche Diagnostics Ltd., West Sussex, 246 
UK), from frozen kidney tissue (25-50mg per sample) using a standard laboratory homogeniser 247 
(Omni-Inc., Kennesaw, Georgia, USA) as per the manufacturer’s instructions, with an additional 248 
chloroform wash step during phase separation. Following isolation, RNA was treated with 249 
TURBO DNA-free Kit (Life Technologies, Bio-Sciences, Dun Laoghaire, Ireland). RNA 250 
quantity and purity was assessed by spectrophotometry with a Nanodrop 1000 (Thermo 251 
Scientific, Wilmington, Delaware, USA). RNA integrity was assessed using an agarose gel 252 
electrophoresis system (E-gel, Life Technologies, Carlsbad, California, USA) and visualization 253 
of clear 18S and 28S ribosomal RNA bands. RNA was reverse transcribed using Transcriptor 254 
First Strand cDNA Synthesis Kit (Roche Diagnostics Ltd.) as per the manufacturer’s 255 
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instructions.  256 
 257 
qPCR 258 
cDNA was amplified using Realtime ready Catalog or Custom Assays (Roche Diagnostics Ltd. 259 
Basal, Switzerland) and Fast Start Essential DNA Probe Master (Roche Diagnostics Ltd. Basal, 260 
Switzerland) as per the manufacturer’s instructions, using the LightCycler 96 (Roche Diagnostics 261 
Ltd. Basal, Switzerland) on 96-well plates. All reactions were performed in duplicate. Data were 262 
normalized to a reference gene, hprt1. Relative expression of HIF-1α, NF-κB, NOS-1, NOS-3, 263 
VEGF, NOX-4 and HO-1 (Roche Diagnostics Ltd. Basal, Switzerland) was calculated using the 264 
ΔΔCT method to normalize expression to the reference gene with changes in expression 265 
displayed as a fold change over the control group. Three sham kidney tissue samples 266 
corresponding with the AIH group were depleted and thus mRNA levels could not be measured 267 
for these animals. Therefore, sham samples corresponding to AIH and CIH studies were pooled 268 
for the purpose of data analysis (sham n=8-10, AIH, n=6 and CIH, n=7). An outlier was removed 269 
from the sham group in the analysis of HO-1 levels.  270 
Calculations 271 
GFR was calculated using: GFR = U*UV/P, where U = urinary [FITC inulin], UV = urine 272 
volume, P = plasma [FITC inulin]. Renal vascular resistance (RVR) was determined by: RVR = 273 
(MAP/RBF). In vivo renal oxygen consumption (QO2) was estimated from the arteriovenous 274 
difference in oxygen content and was given by: QO2 = arterio-venous difference in oxygen 275 
content*RBF, where blood oxygen content = 1.34* Hemoglobin oxygen saturation*Hemoglobin 276 
concentration+blood PO2*0.003). Tubular sodium transport (TNa) was calculated by: TNa = 277 
[PNa]*GFR-[UNa]*UV, where [PNa] = plasma sodium concentration and [UNa] = urinary 278 
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sodium concentration. Fractional sodium excretion = sodium clearance/GFR, where sodium 279 
clearance= [UNa]*UV/[PNa]. 280 
Statistical analysis 281 
Data are presented as mean ± SEM. All statistical analyses were performed using GraphPad 282 
Prism (GraphPad Software, San Diego, CA, USA). All data were analyzed using 2x2 ANOVA 283 
with a Bonferroni post–hoc test unless otherwise specified. There were 2 multiple comparisons 284 
made per family. Differences were deemed to be statistically significant when P< 0.05. The 285 
critical value of P in this context was two sided. Ordinary least products regression analysis 286 
(Deming model II) was used to calculate lines of best fit for TNa and QO2. Renal mRNA 287 
expression levels of NF-κB, HIF-1α, NOS-1, NOS-3, NOX4, HO-1 and VEGF were analyzed 288 
using a one way ANOVA. Urinary KIM-1 levels in sham versus CIH animals were compared 289 







General  297 
Exposure of animals to either AIH or CIH had no significant effect on body weight (Table 1). 298 
The partial pressure of oxygen in arterial blood (PaO2) was higher and the partial pressure of 299 
carbon dioxide in arterial blood (PaCO2) was lower in animals exposed to CIH compared with 300 
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sham control group (Table 1), revealing a mild persistent hyperventilation with metabolic 301 
compensation, indicative of long-term facilitation (LTF) of breathing (22), which can persist 302 
under normoxic conditions for as long as 3 days following exposure to CIH (22,23). Hematocrit 303 
and hemoglobin levels in arterial blood were significantly elevated in animals exposed to CIH 304 
compared with the corresponding sham control group (Table 1). 305 
 306 
Hemodynamic parameters 307 
Exposure to AIH had no significant effect on MAP, whereas animals exposed to CIH were 308 
hypertensive compared with the corresponding controls (Fig 2A). Exposure of animals to AIH 309 
resulted in an increase in GFR and RBF (both P<0.05), whereas exposure of animals to CIH had 310 
the opposite effect (Interaction: Gas x Duration: P=0.004) and P=0.005, respectively) (Fig 2B 311 
and C). Correspondingly, RVR was lower in the animals exposed to AIH and higher in the 312 
animals exposed to CIH (Interaction: Gas x Duration: P=0.004) (Fig 2D).  313 
 314 
Excretory parameters (Table 2) 315 
UF, UNaV, FENa and sodium clearance were not significantly altered by either AIH or CIH 316 
exposures. However, the results of the 2-way ANOVA performed on the UF data revealed a 317 
significant interaction, with opposing effects on this variable in the context of acute versus 318 
chronic exposures (Table 2). Urinary protein excretion (UPE) was not significantly different 319 
between animals exposed to AIH and the corresponding sham control group. Conversely, a 320 
modest proteinuria was evident in animals exposed to CIH (P=0.09) (Table 2). 321 
 322 
Sodium Transport and Renal Oxygen Consumption  323 
Sodium transport (TNa) was greater in animals exposed to AIH, whereas TNa was reduced in 324 
animals exposed to CIH (Interaction: Gas x Duration: P=0.002) (Fig 3A). Renal oxygen 325 
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consumption (QO2) was also greater in animals exposed to AIH (Fig 3B). Conversely, exposure 326 
of animals to CIH had no significant impact on QO2 (Fig 3B). The relationship between TNa and 327 
QO2 was also examined using regression analysis in groups exposed to either AIH or CIH. The 328 
slope of the relationship between TNa and QO2 was compared (Fig 3C and D). Neither AIH nor 329 
CIH significantly affected the slope of the relationship between TNa and QO2 (Fig 3C and D). 330 
We interpret this to mean that sham and IH animals exhibit the same increase in renal QO2 per 331 
unit change TNa (no difference in the efficiency of TNa). However, the elevation of the 332 
relationship between TNa and QO2 was significantly greater in animals exposed to CIH 333 
(P=0.001). Thus, at any given TNa, CIH animals exhibit a significantly higher renal QO2. 334 
 335 
Renal Oxygen Tension 336 
Exposure of animals to AIH had no significant effect on tissue oxygen availability in either the 337 
renal cortex or medulla (Fig 4A and B). Conversely, exposure to CIH was associated with 338 
significantly lower PO2 in the renal cortex compared with corresponding sham controls. There 339 
was no significant difference in medullary PO2 values between CIH and sham groups (Fig 4A 340 
and B).  341 
 342 
Nitric Oxide  343 
NO was measured in the plasma, urine and in the renal cortex and medulla in all groups (Table 344 
3). Urinary NOx excretion was similar in all groups. NOx concentration in the plasma and renal 345 
cortex was significantly lower both in AIH and CIH groups compared with corresponding sham 346 
control groups.   347 
 348 
Oxidative Stress  349 
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TBARS concentration was measured in the plasma and in the renal cortex and medulla (Table 3) 350 
in all groups. Enhanced lipid peroxidation was not evident in animals exposed to either AIH or 351 
CIH in plasma, renal cortex or renal medulla.  352 
 353 
Inflammatory Profile: Renal Cortex  354 
IFN- γ  levels were significantly increased in animals exposed to AIH (Table 4). The 355 
concentrations of the other detectable inflammatory cytokines in renal cortex did not 356 
significantly differ between groups (Table 4).  357 
 358 
Gene expression: Whole kidney 359 
Renal NF-κB, HIF-1α, HO-1, VEGF, NOS-1, NOS-3 and NOX-4 gene expression did not 360 









Discussion: 370  371 
The present study sought to determine the impact of IH exposure on renal function and oxygen 372 
homeostasis with a view to a better understanding of the potential role this stimulus might play in 373 
the pathogenesis of CKD. To this end, animals were exposed to a moderate IH profile (similar to 374 
what might be observed in patients with OSA) either acutely for four hours or chronically for 375 
eight hours per day for two weeks prior to the in vivo measurement of renal hemodynamics, 376 
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excretory function and oxygen homeostasis. The first finding of the present study was that renal 377 
tissue oxygen availability (PO2) was preserved in animals exposed to AIH due to reciprocal 378 
increases in renal QO2, and O2 delivery via RBF. The second finding was that significant 379 
decreases in tissue oxygen was evident in the renal cortex of animals exposed to CIH, which 380 
most likely resulted from elevations in transport unrelated oxygen consumption (basal 381 
metabolism). Importantly, the altered NO bioavailability and sustained decrease in tissue PO2 in 382 
the renal cortex of animals exposed to CIH is consistent with previous observations in other 383 
animal models of CKD, such as diabetes and hypertension (28, 30, 33, 34, 38, 40, 55).   384 
 385 
In the present study, both RBF and GFR were higher and RVR was lower in animals exposed to 386 
IH for four hours. Viewed collectively, these data provide evidence for an acute hyperemia and 387 
afferent arteriolar dilation (7,45). Analysis of the kidney tissue was carried out in an effort to 388 
determine possible mechanisms underlying IH-induced hyperemia. The potential role played by 389 
NO in mediating this response is not entirely clear at present. Indeed plasma and renal tissue 390 
levels of NOx metabolites reveal that a four hour IH exposure decreased NO production. This 391 
observation is consistent with the findings of others in mouse aorta (52), but is not consistent 392 
with the observed hyperemia in the present study. Indeed, exposure to AIH had no significant 393 
impact upon NOS-1 or NOS-3 mRNA expression levels, indicating that endothelial and neuronal 394 
nitric oxide synthase were unaffected at a transcriptional level. However, the present 395 
observations are limited because we did not measure for NOS-1 and NOS-3 activity levels, 396 
which could potentially be altered thereby accounting for the decrease in NOx metabolites 397 
observed in the present study. It is also important to acknowledge that the regulation of NO 398 
bioavailability/activity is complex and not just solely dependent upon NOS-mediated NO 399 
production per se. It can also be influenced by other factors such as arginase activity, L-citrulline 400 
concentration, superoxide anion production and the availability of NO associated signaling 401 
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molecules such as soluble guanylate cyclase (sGC) and cyclic guanosine monophosphate 402 
(cGMP) (39, 57). Thus, NO cannot be ruled out as a potential mediator of the hyperemia 403 
observed in the AIH group.  404 
 405 
 Kidney tissue was also investigated for evidence of Hemeoxygenase-1 (HO-1) upregulation at 406 
the transcriptional level because HO-1 synthesizes carbon monoxide (CO) a potent vasodilator. 407 
Previous studies have demonstrated that acute IH exposure and ischemia reperfusion injury are 408 
both coincident with HO-1 upregulation in the liver, brain and kidney tissue (21, 44, 50). AIH 409 
exposure had no significant effect on HO-1 expression and thus there is no evidence that CO was 410 
mediating the renal hyperemia observed in the present study. Of interest, the cytokine profile 411 
analysis of renal cortical tissue demonstrated that IFN-γ levels were significantly increased 412 
following AIH exposure. IFN-γ is an inflammatory cytokine that is known to acutely dilate 413 
resistance arteries in uterine tissue (5, 16). Indeed, the literature suggests that an acute elevation 414 
in IFN-γ, stimulates inducible NOS (iNOS) in endothelial cells, which can in turn increase local 415 
NO production (26). We did not measure iNOS expression or activity and thus the potential role 416 
of the IFN-γ/iNOS/NO pathway in mediating renal hyperemia in response to an acute exposure 417 
to IH should be addressed in subsequent studies.  418 
 419 
AIH-induced alterations in hemodynamic parameters were paralleled by reciprocal alterations in 420 
metabolism, as evidenced by heightened TNa and QO2. Consistent with the observations of 421 
others in several animal models, increased TNa and QO2 observed in the present study is most 422 
likely related to increases in GFR (9, 15, 30, 35).  Indeed, it is now well established that 423 
pathological or pharmacological elevations in GFR result in corresponding increases in the 424 
filtered load of sodium, which in turn increase the reabsorptive work of the kidney, particularly 425 
in the proximal tubules (9, 15, 30) The increased TNa observed in this study following AIH 426 
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exposure reflects a rise in the activity of tubular sodium transporters whose function is either 427 
primarily or secondarily dependent upon the hydrolysis of ATP. The linear relationship between 428 
TNa and QO2 was not altered by AIH exposure, indicating that the raised QO2 was solely related 429 
to a reciprocal rise in TNa of equal magnitude, and was not due to reductions in the efficiency of 430 
TNa (9,10). Overall these data suggest that the elevated QO2 observed in AIH rats resulted from 431 
an increase in the transport related demand for ATP. Importantly, under these experimental 432 
conditions renal tissue oxygen availability in the cortex and medulla was maintained within 433 
normal limits because the balance was preserved between oxygen supply and demand.  434 
 435 
In agreement with previous reports, animals exposed to CIH were hypertensive (17, 20, 49). Of 436 
interest, in the present study, CIH exposure had opposing effects on renal hemodynamics 437 
compared with AIH, such that animals presented with a relatively lower RBF and GFR, and a 438 
higher RVR. The hemodynamic changes in response to CIH were accompanied by a modest 439 
proteinuria, which is manifest in a proportion patients with OSA (8, 24), and consistent with CIH 440 
induced structural changes in the glomeruli in an animal model (1). Also of note was a 43% 441 
increase in urinary KIM-1 excretion rate in animals exposed to CIH, which is indicative of 442 
proximal tubular injury at the very early stages of CKD (18). Importantly, the above 443 
hemodynamic responses observed in this study are consistent with the reported impact of IH on 444 
vascular reactivity in other tissues. CIH exposure has been shown to increase the vasoconstrictor 445 
response to endothelin and norepinephrine in rat mesenteric arteries (3) and in the vascular bed 446 
of the rat cremaster muscle (51), indicating that CIH primes the blood vessels for constriction. 447 
Importantly, Tahawi et al 2001 also observed weakened vasoconstrictor responses to the NOS 448 
inhibitor L-NAME, indirectly indicating that these blood vessels have impaired vasodilation due 449 
to reductions in the production of NO (51). In the present study, CIH-induced reductions in GFR 450 
and RBF were associated with a decrease in NO metabolites both systemically and in renal 451 
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tissue, indicating that vasoconstriction was associated with a concomitant reduction in the 452 
production of NO. These observations are in agreement with the current literature where it is 453 
well established that reduced NO production impairs renal blood perfusion (13).  454 
 455 
On the other hand, there was no association between the reductions in RBF and GFR observed in 456 
CIH-exposed animals and oxidative stress (as measured by lipid peroxidation), with equivalent 457 
levels both in the plasma and kidney tissue of all groups. These data were surprising given that 458 
reactive oxygen species (ROS) are known vasoconstrictors and have been reported to accumulate 459 
both systemically and in the kidney in mouse and rat models of CIH (19, 37, 48). However, in 460 
the latter studies, ROS accumulation was only evident after more than 6-8 weeks of exposure, 461 
substantially longer than the 2 week exposure to IH used in the present study. These studies also 462 
demonstrated that antioxidant enzymes such as superoxide dismutase (SOD) were upregulated 463 
after 3 days of IH exposure. Of interest, SOD is downregulated after 8 weeks of exposure to IH, 464 
which coincided with the renal accumulation of ROS (48). In the context of the present study, it 465 
may well be that there was an upregulation in the expression and activity of antioxidant enzymes 466 
accounting for the absence of ROS accumulation in the plasma and kidney of rats exposed to 467 
CIH, and perhaps AIH.  468 
 469 
The metabolic consequences of the diminished GFR observed in animals exposed to CIH were 470 
reflected in corresponding reductions in TNa, but not in QO2. The regression analysis performed 471 
on this data set indicates that the nature of the relationship between the two variables was altered 472 
in the CIH group, such that global renal QO2 was significantly greater at any given level of TNa. 473 
These observations suggest that sodium transport efficiency was reduced in the CIH group. 474 
Indeed, one might be tempted to assume that a decrease in GFR and thereby the proximal 475 
reabsorption of sodium could potentially lead to a compensatory shift in TNa to more distal 476 
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nephron segments where the metabolic cost of sodium reabsorption is higher, i.e. the medullary 477 
thick ascending limb (mTAL) (9, 14, 30). However, in the context of the present study this is 478 
unlikely because MPO2 was not significantly decreased in conjunction with GFR and TNa.  479 
 480 
Alternatively these data could reflect an increase in transport unrelated QO2/basal metabolism, 481 
which could also potentially explain why QO2 was not decreased in conjunction with TNa and 482 
GFR in the group exposed to CIH. Renal NO metabolites were also reduced significantly in the 483 
renal cortex of animals exposed to CIH indicating a possible reduction in the biosynthesis of NO. 484 
Thus one plausible cause for the observed discrepancy between GFR/TNa and QO2 in the present 485 
study is that a reduction in NO bioavailability diminished the tonic inhibitory effect of NO on 486 
mitochondrial respiration, thereby increasing basal mitochondrial QO2 (15, 25, 57). Whether, the 487 
mismatch between TNa and QO2 resulted from an increase in transport related QO2 or basal 488 
metabolism is unclear.  Either way, the net effect was a reduction in tissue PO2 in the renal 489 
cortex in animals exposed to CIH. Importantly, these observations are consistent with previous 490 
observations of others in various animal models of kidney disease (28, 30, 33, 34, 55).  491 
 492 
It has been reported that chronic sustained decreases in oxygen availability in the kidney activate 493 
pro-inflammatory pathways (Ohtomo et al 2008, Nordquist et al 2015). Moreover, experimental 494 
data suggests that renal HIF-1α activation contributes to the activation of pro-inflammatory 495 
pathways in animal models of diabetes (28, 31). In the present study, CIH-induced reduction in 496 
cortical tissue oxygen tension was not associated with HIF-1α or NF-κB activation at the 497 
transcriptional level, although there was a trend for elevated levels in the CIH-exposed kidney. 498 
Moreover, exposure to CIH did not significantly affect the transcriptional expression of other 499 
HIF response genes such as NOS-1, NOS-3, VEGF or HO-1. On the contrary, blood gas analysis 500 
revealed that hemoglobin and hematocrit were both significantly elevated in CIH-exposed 501 
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animals, providing some indirect evidence of renal  HIF-1α induced up-regulation of 502 
erythropoietin, a HIF response gene (42, 47), perhaps transiently, over the course of the 2 week 503 
exposure to IH. Others have demonstrated IH-induced renal tissue HIF-1α upregulation from 504 
weeks 6-9 following the onset of IH exposure (19). In agreement with the present observations, 505 
Sun et al. 2015 demonstrated that HIF-1α protein expression was not significantly upregulated in 506 
mice exposed to IH for 2 weeks (48), suggesting that HIF-1α maybe transiently activated during 507 
2 weeks of IH exposure, whereas longer duration exposures may result in a more sustained 508 
period of HIF-1α activation.  509 
 510 
Finally, the present study provides no evidence for a pronounced renal inflammatory response 511 
after 2 weeks of IH exposure either at the gene or protein level, with IFN-γ the only 512 inflammatory cytokine that was found to be increased in the renal cortex following 513 exposure to IH. Of note, Lu et al 2017 observed increases in TNF-α and IL-6 only after 6 weeks 514 
of IH exposure in rats and Sun et al 2015 demonstrated that inflammatory markers such as cell 515 
adhesion molecules (ICAM1) and plasminogen activator inhibitor (PAI) were equivalent to 516 
control levels following a 2 week exposure to IH in mice (19, 48). Our data suggest that a 2 week 517 
exposure to IH and the resultant decrease in cortical tissue oxygen tension at this early stage 518 
were not associated with a robust inflammatory response in the renal cortex. We speculate that 519 
IH exposures of longer duration potentially result in decreases in renal oxygen tension of greater 520 
magnitude, which in turn could stimulate a more robust inflammatory response.  521 
 522 
Limitations:  523 
It is not clear whether the reduction in renal cortex oxygen tension observed in animals exposed 524 
to CIH was related to intermittent hypoxia per se or whether it is a consequence of hypertension. 525 
It is established that kidney tissue hypoxia is present in animal models of hypertension such as 526 
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the spontaneously hypertensive rat (SHR) (54, 56). Impaired renal blood flow may in part 527 
contribute to kidney tissue hypoxia in the SHR, but reductions in the efficiency of oxygen 528 
utilization for sodium transport have also been reported to play a major role (54). Thus it may 529 
well be that the dysregulated oxygen homeostasis observed in the present study is an indirect 530 
consequence of IH-induced hypertension as opposed to renal tissue IH per se.  It would be 531 
interesting to explore the temporal changes in renal tissue oxygen tension in the transition from 532 
short-term to long-term IH exposure and the development of hypertension. Renal tissue hypoxia 533 
and consequential aberrant afferent signaling from the kidneys to the brainstem may be a critical 534 
component of the development and/or maintenance of high blood pressure (36). Another 535 
limitation of the present study is that we did not measure tissue levels of superoxide or 536 
antioxidant enzymes. Thus the putative role of altered redox signaling in the kidney in response 537 
to IH exposure remains unclear.  538 
 539 
Conclusions:  540 
The metabolic consequences of increased GFR in animals exposed to AIH are reflected by 541 
corresponding increases in TNa and QO2. Renal PO2 was not altered in conjunction with QO2 542 
indicating that AIH exposure activates a compensatory mechanism in the kidney whereby O2 543 
delivery (RBF) and consumption, although elevated remain balanced, thereby preserving tissue 544 
O2 availability. The metabolic consequences of a diminished GFR in animals exposed to CIH 545 
were reflected by reductions in TNa, but not in QO2. The mismatch between TNa and QO2 546 
reflects a decrease in the metabolic efficiency of sodium transport. Consequently, a decrease in 547 
tissue PO2 in the renal cortex was evident after 2 weeks of CIH exposure. These perturbations in 548 
renal function and oxygen homeostasis were associated with corresponding reductions in the 549 
systemic and renal production of NO metabolites. It is clear that 2 weeks of CIH exposure 550 
induces changes in renal function and oxygen homeostasis that are consistent with aspects of the 551 
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current understanding of CKD. However, the precise mechanisms by which cortical tissue 552 
hypoxia might contribute to CKD in this model require further investigation. Moreover, future 553 
studies are needed to determine the impact of IH exposure on kidney oxygen homeostasis 554 
preceding the development of the CIH-induced hypertensive phenotype. 555 
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Figure Legends 789 
Figure 1  790 
Schematic of the experimental protocol. AIH, acute intermittent hypoxia; CIH, chronic 791 
intermittent hypoxia; CPO2, cortical oxygen tension; MPO2, medullary oxygen tension; FITC, 792 
fluorescein iosthiocyanate.  793 
Figure 2  794 
Mean Arterial Pressure (A), glomerular filtration rate (B), renal blood flow (C) and renal 795 
vascular resistance in sham control groups (closed bars) and in animals exposed to intermittent 796 
hypoxia (IH, open bars) for 4 hours (acute) or for 8 hours/day for 2 weeks (chronic). * denotes 797 
P<0.05 versus corresponding sham value; # denotes P<0.05 versus corresponding exposure 798 
group. Bonferroni post hoc test was used for multiple comparisons where appropriate; 2 799 
comparisons were performed per family, alpha=0.05 800 
Figure 3  801 
Transported sodium (A), and renal oxygen consumption (B) in sham control groups (closed bars) 802 
and in animals exposed to intermittent hypoxia (IH, open bars) for 4 hours (acute) or for 8 803 
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hours/day for 2 weeks (chronic). C shows regression (Deming Model II) analysis examining the 804 
relationship between sodium transport and oxygen consumption in the AIH group (green) and 805 
the corresponding sham group (pink). D shows regression analysis (Deming Model II) 806 
examining the relationship between sodium transport and oxygen consumption in the CIH group 807 
(purple) and the corresponding sham (pink). * denotes P<0.05 versus corresponding sham value; 808 
# denotes P<0.05 versus corresponding exposure group. Bonferroni post hoc test was used for 809 
multiple comparisons where appropriate; 2 comparisons were performed per family, alpha=0.05 810 
Figure 4  811 
Renal cortex oxygen tension (A), and renal medulla oxygen tension (B) in sham control groups 812 
(closed bars) and in animals exposed to intermittent hypoxia (IH, open bars) for 4 hours (acute) 813 
or for 8 hours/day for 2 weeks (chronic). * denotes P<0.05 versus corresponding sham value; # 814 
denotes P<0.05 versus corresponding exposure group. Bonferroni post hoc test was used for 815 
multiple comparisons where appropriate; 2 comparisons were performed per family, alpha=0.05 816 
 817 
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Table1: The effect of AIH and CIH on body weight, arterial blood gases, [Hb] and hematocrit  





pH PaO2 (kPa) PaCO2 
(kPa) 
[Hb] (g/L) HCT (%) 
Acute  Sham 
 
292±19 23.27±0.61 7.40±0.02 9.82±0.61 5.08±0.25 150.00±4.79 50.33±2.79 
    
  IH 
 
314±20 22.03±0.66 7.40±0.01 10.64±0.31 4.81±0.23 148.43±3.90 52.71±1.23 
   
 
 
Chronic  Sham 
 
298±12 25.41±0.50 7.38±0.05 9.05±0.50 5.84±0.28 148.78±5.09 44..56±1.49 
   
 
 
  IH 
 
286±16 23.44±0.80 7.43±0.02 11.68±0.28* 4.73±0.01* 176.71±8.82#* 53.00±*2.66 
      
2X2 ANOVA  Gas 
 
P=0.77 P=0.01 P=0.12 P=0.001 P=0.02 P=0.04 P=0.02  
  Duration 
 




P=0.32 P=0.84 P=0.10 P=0.06 P=0.15 P=0.02 P=0.15 
    
 Data were analyzed using a 2X2 ANOVA and a Bonferroni post –hoc test with 2 multiple comparisons. Data are expressed as mean ± SEM. HCT, hematocrit; Hb, hemoglobin; [HCO3-], Bicarbonate concentration in the arterial blood; PaO2, arterial oxygen tension; PaCO2, arterial carbon dioxide tension; IH, intermittent hypoxia; * denotes P<0.05 versus corresponding sham value; # denotes P<0.05 versus corresponding gas group value. 
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Table 2. Renal excretory effects of AIH and CIH  
   Urine Flow 




















2.44± 0.30 0.32±0.09 2.20±0.65 0.26±0.08 68.26±16.50           ---   
 
       IH 
 
6.05±1.25 0.89±0.28 6.12±1.95 0.44±0.14 68.58±8.02           ---   
 
      
Chronic Sham 
 
5.39±1.27 0.65±0.24 5.00±1.72 0.40±0.14 64.52±4.47 0.53±0.12   
 
       IH 
 
3.39±1.05 0.42±0.15 2.92±1.07 0.34±0.14 132±41.49 0.93±0.26    
 
      
2X2 
ANOVA Gas  P=0.23 P=0.44 P=0.47 P=0.56 P=0.09  
 Duration 
 




P=0.03 P=0.06 P=0.06 P=0.37 P=0.16  
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Data were analyzed using a 2X2 ANOVA and a Bonferroni post –hoc test with 2 multiple comparisons carried out per family. Data are expressed as mean ± SEM. IH, intermittent hypoxia; KIM-1, Kidney injury marker-1. Urinary KIM-1 excretion data was analyzed using an unpaired t-test comparing sham (n=5) and CIH (n=5); P = 0.2046.    






























Sham  1.10±0.41 15.92±1.37 15.03±1.11 18.32±1.28 0.35±0.14 0.50±0.04 0.13±0.003 
          
 IH 
 
 1.62±0.23 11.35±0.78* 15.58±0.93 11.61±1.28* 0.30±0.03 0.49±0.05 0.13±0.01 
          
Chronic 
 
Sham  1.43±0.32 16.77±2.12 13.99±0.73 17.30±1.19 0.24±0.03 0.61±0.08 0.10±0.01# 
          
 IH 
 








Gas  P=0.46 P=0.0003 P=0.18 P<0.0001 P=0.56 P=0.16 P=0.56 
 Duration 
 
 P=0.83 P=0.80 P=0.01 P=0.19 P=0.14 P=0.69 P=0.03 
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 Data were analyzed using a 2X2 ANOVA and a Bonferroni post –hoc test with 2 multiple comparisons carried out per family. Data are  expressed as mean ± SEM. IH, intermittent hypoxia; NOx, Nitrate/Nitrite metabolites; TBARS, Thiobarbituric acid reactive substances. * denotes P<0.05 versus corresponding sham value; # denotes P<0.05 versus corresponding gas group value.                             
 Interaction  P=0.44 P=0.35 P=0.06 P=0.47 P=0.80 P=0.20 P=0.18 
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    Data were analyzed using a 2X2 ANOVA and a Bonferroni post –hoc test with 2 multiple comparisons carried out per family. Data are  























Sham  1.19±0.23 23.21±2.71 93.48±23.53 63.40±5.42 4.82±0.88 2.00±0.18 
         
 IH 
 
 3.94±1.11 35.34±8.67 229.72±93.42 66.27±15.28 3.40±0.89 3.35±1.36 
         
Chronic 
 
Sham  2.70±1.15 35.61±5.27 117.24±24.66 62.26±8.38 3.03±0.68 2.36±0.46 
         
 IH 
 


















 P=0.67 P=0.20 P=0.13 P=0.09 P=0.58 P=0.20 
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expressed as mean ± SEM. IH, Intermittent hypoxia; IFN-γ, Interferon-γ; IL-1β, Interleukin-1β; IL-6, Interleukin-6; KC/GRO, chemokine/growth related oncogene; IL-10, interleukin-10; TNF-α, Tumor necrosis factor-α.  
 
 
Table 5 Impact of AIH and CIH on renal gene expression  
    NOS-1 NOS-3 VEGF NOX 4 HO-1 HIF-1α NF-κB 
Groups  Pooled Sham 
 
1.05±0.13 1.11±0.16 1.01±0.05 1.01±0.16 1.21±0.28 0.97±0.13 0.92±0.08 
  AIH  
 
1.12±0.15 1.11±0.07 1.09±0.07 1.03±0.14 0.72±0.22 1.01±0.11 0.88±0.17 
  CIH  
 
1.48±0.22 1.50±0.14 1.24±0.11 1.44±0.18 0.84±0.21 1.34±0.27 1.73±0.50 
         
ONE WAY  
ANOVA 
P-Value 0.19 0.09 0.13 0.14 0.34 0.33 0.08 
 Data were analyzed using a one-way ANOVA with a Bonferroni pot-hoc test with 2 multiple comparisons carried out per family. mRNA levels are expressed as fold change relative to the HPRT reference gene. Data are expressed as mean ± SEM. AIH, acute intermittent hypoxia; CIH, chronic intermittent hypoxia; NOS-1; neuronal nitric oxide synthase; NOS-3 endothelial nitric oxide synthase; VEGF vascular endothelial growth factor; NOX 4 NADPH (nicotinamide adenine dinucleotide phosphate hydrogen) oxidase 4; HO-1, haemoxygenase 1; HIF, hypoxia inducible factor; NF-κB, nuclear factor kappa B. 
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